BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9752414)

  • 1. [Local, non-surgical treatment of hepatocellular carcinoma].
    Roche A
    Ann Chir; 1998; 52(1):75-8. PubMed ID: 9752414
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?
    Yamashita T
    J Gastroenterol; 2004; 39(4):404-6. PubMed ID: 15168258
    [No Abstract]   [Full Text] [Related]  

  • 3. Transarterial chemoembolization for hepatocellular carcinoma.
    Lau WY; Yu SC; Lai EC; Leung TW
    J Am Coll Surg; 2006 Jan; 202(1):155-68. PubMed ID: 16377509
    [No Abstract]   [Full Text] [Related]  

  • 4. Closing remarks.
    Kudo M
    Clin Drug Investig; 2012 Aug; 32 Suppl 2():52. PubMed ID: 22873627
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatocellular carcinoma complicating cirrhosis. Therapeutic possibilities].
    Porcheron J; Cadi F; Tardieu D; Balique JG
    Ann Gastroenterol Hepatol (Paris); 1992; 28(3):131-9. PubMed ID: 1325136
    [No Abstract]   [Full Text] [Related]  

  • 6. Intra-arterial versus systemic chemotherapy for non-operable hepatocellular carcinoma.
    Tzoracoleftherakis EE; Spiliotis JD; Kyriakopoulou T; Kakkos SK
    Hepatogastroenterology; 1999; 46(26):1122-5. PubMed ID: 10370678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatments for resectable hepatocellular carcinoma.
    Ishii H; Yamamoto J; Ikari T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):459-62. PubMed ID: 18836796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which transarterial therapy is best for hepatocellular carcinoma?--the evidence to date.
    Tsochatzis E; Meyer T; Marelli L; Burroughs AK
    J Hepatol; 2010 Sep; 53(3):588. PubMed ID: 20472319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of local lipiodol chemoembolization therapy in primary and secondary hepatic tumors].
    András C; Szúcs Farkas Z; Csiki Z; Gál I; Takács I; Sápy P; Péter M
    Orv Hetil; 2000 Aug; 141(32):1773-7. PubMed ID: 10979306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subselective intra-arterial chemotherapy infusion in the treatment of hepatocellular carcinoma.
    Daniels JR; Wallman M
    Semin Oncol; 2010 Apr; 37(2):83-8. PubMed ID: 20494699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technologies for ablation of hepatocellular carcinoma.
    Callstrom MR; Charboneau JW
    Gastroenterology; 2008 Jun; 134(7):1831-5. PubMed ID: 18486619
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatocellular carcinoma: current management and perspectives for the future.
    Rahbari NN; Mehrabi A; Mollberg NM; Müller SA; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):453-69. PubMed ID: 21263310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of hepatocellular carcinoma. New developments].
    Kuiken SD; van Delden OM; Richel DJ; Jansen PL
    Ned Tijdschr Geneeskd; 2009 Apr; 153(14):668-72. PubMed ID: 19425326
    [No Abstract]   [Full Text] [Related]  

  • 14. Massive gastric ulceration after transarterial chemoembolization for hepatocellular carcinoma.
    Morante A; Romano M; Cuomo A; de Sio I; Cozzolino A; Mucherino C; Salerno R; Blanco Cdel V; Romano M
    Gastrointest Endosc; 2006 Apr; 63(4):718-20. PubMed ID: 16564887
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intra-arterial chemo-embolisation and portal vein embolisation prior to liver resection].
    Arguimbau LO; Rasmussen A; Larsen PN
    Ugeskr Laeger; 2008 Feb; 170(7):549. PubMed ID: 18291087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinative treatment of transarterial chemoembolization, celecoxib and lanreotide in unresectable hepatocellular carcinoma.
    Tong H; Li X; Wei B; Tang C
    Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):e65-6. PubMed ID: 25746137
    [No Abstract]   [Full Text] [Related]  

  • 18. Out of control: hepatitis B reactivation by transarterial treatment of hepatocellular carcinoma.
    von Weizsäcker F; Blum HE
    J Hepatol; 2004 Sep; 41(3):482-4. PubMed ID: 15336452
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma.
    Barone M; Ettorre GC; Ladisa R; Schiavariello M; Santoro C; Francioso G; Vinciguerra V; Francavilla A
    Hepatogastroenterology; 2003; 50(49):183-7. PubMed ID: 12630019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.